We are live on
!
Find out more
Vir Biotechnology
204 hedge funds and large institutions have $2.09B invested in Vir Biotechnology in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 84 increasing their positions, 44 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
91% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 44
62% more call options, than puts
Call options by funds: $16.7M | Put options by funds: $10.3M
1.66% more ownership
Funds ownership: 59.67% → 61.33% (+1.7%)
4% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 49
3% less funds holding
Funds holding: 210 → 204 (-6)
36% less capital invested
Capital invested by funds: $3.25B → $2.09B (-$1.16B)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
204
Holders Change
-6
Holders Change %
-2.86%
% of All Funds
3.22%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.06%
New
47
Increased
84
Reduced
44
Closed
49
Calls
$16.7M
Puts
$10.3M
Net Calls
+$6.41M
Net Calls Change
+$7.59M
Top Buyers
| 1 |
Millennium Management
New York
|
+$112M |
| 2 |
State Street
Boston,
Massachusetts
|
+$49.4M |
| 3 |
GF
Gates Foundation
Seattle,
Washington
|
+$26.1M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7M |
